Activation of the extracellular signal-related kinase/mitogen-activated protein kinase pathway discriminates CD4 versus CD8 lineage commitment in the thymus

Journal of Immunology

Volumn 163, Issue 2, 1999, Pages 715-722

  Bommhardt, Ursula ^a,b   Basson, M Albert ^a   Krummrei, Ulrike ^a   Zamoyska, Rose ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b Inst Virologie and Immunobiologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENZYME ACTIVATOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; UO 126;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HELPER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMUS; TRANSGENE;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; IMMUNE SERA; IMMUNOGLOBULIN FRAGMENTS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN CULTURE TECHNIQUES; SIGNAL TRANSDUCTION; THYMUS GLAND;

EID: 0033565424     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Itano, A., P. Salmon, D. Kioussis, M. Tolaini, P. Corbella, and E. Robey. 1996. The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells. J. Exp. Med. 183:731.
2. Matechak, E. O., N. Killeen, S. M. Hedrick, and B. J. Fowlkes. 1996. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 4:337.
3. Veillette, A., J. C. Zœñiga-Pflücker, J. B. Bolen, and A. M. Kruisbeek. 1989. Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J. Exp. Med. 170:1671.
4. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
5. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H.-P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651.
6. Basson, M. A., U. Bommhardt, M. S. Cole, J. Y. Tso, and R. Zamoyska. 1998. CD3 ligation on immature thymocytes generates antagonist-like signals appropriate for CD8 lineage commitment, independently of T cell receptor specificity. J. Exp. Med. 187:1249.
7. Volkmann, A., T. Barthlott, S. Weiss, R. Frank, and B. Stockinger. 1998. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage. J. Exp. Med. 188:1083.
8. Müller, K.-P., and B. A. Kyewski. 1995. T cell receptor (TcR) targeting in mice lacking CD4 or major histocompatibility complex (MHC) class II: rescue of CD4 T cell lineage without co-engagement of TCR/CD4 by MHC class II. Eur. J. Immunol. 25:896.
9. + T cells by TCR ligation without aggregation even in the absence of MHC. Nature 371:67.
10. + thymocytes to the CD4 lineage without TCR engagement. Int. Immunol. 8:297.
11. Takahama, Y., and H. Nakauchi. 1996. Phorbol ester and calcium ionophore can replace TCR signals that induce positive selection of CD4 T cells. J. Immunol. 157:1508.
12. Cibotti, R., J. A. Punt, K. S. Dash, S. O. Sharrow, and A. Singer. 1997. Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals. Immunity 6:245.
13. Bommhardt, U., M. S. Cole, J. Yun Tso, and R. Zamoyska. 1997. Signals through CD8 or CD4 can induce commitment to the CD4 lineage in the thymus. Eur. J. Immunol. 27:1152.
14. Basson, M. A., U. Bommhardt, P. J. Mee, V. L. J. Tybulewicz, and R. Zamoyska. 1998. Molecular requirements for lineage commitment in the thymus: antibody-mediated receptor engagements reveal a central role for Lck in lineage decisions. Immunol. Rev. 165:181.
15. Dudley, D., L. Pang, S. Decker, A. Bridges, and A. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
16. Favata, M., K. Horiuchi, E. Manos, A. Daulerio, D. Stradley, W. Feeser, D. Van Dyk, W. Pitts, R. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623.
17. + cytolytic T cells. Nature 344:742.
18. Cosgrove, D., D. Grey, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
19. Spanopoulou, E., C. Roman, L. Corcoran, M. Schlissel, D. Silver, D. Nemazee, M. Nussenweig, S. Shinton, R. Hardy, and D. Baltimore. 1994. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1 deficient mice. Genes Dev. 8:1030.
20. Mamalaki, C., J. Elliot, T. Norton, N. Yannoutsos, A. R. Townsend, P. Chandler, E. Simpson, and D. Kioussis. 1993. Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev. Immunol. 3:159.
21. Zal, T., A. Volkmann, and B. Stockinger. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180:2089.
22. Kostelny, S. A., M. S. Cole, and J. Yun Tso. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148:1547.
23. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony stimulating factor. J. Exp. Med. 176:1693.
24. Swan, K. A., I. J. Alberola, J. A. Gross, M. W. Appleby, K. A. Forbush, J. F. Thomas, and R. M. Perlmutter. 1995. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J. 14:276.
25. Alberola-Ila, J., K. A. Forbush, R. Seger, E. G. Krebs, and R. M. Perlmutter. 1995. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373:620.
26. Alberola-Ila, J., K. Hogquist, K. Swan, M. Bevan, and R. M. Perlmutter. 1996. Positive and negative selection invoke distinct signalling pathways. J. Exp. Med. 184:9.
27. Sharp, L. L., D. A. Schwarz, C. M. Bott, C. J. Marshall, and S. M. Hedrick. 1997. The influence of the MAPK pathway on T cell lineage commitment. Immunity 7:609.
28. Sugawara, T., T. Moriguchi, E. Nishida, and Y. Takahama. 1998. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity 9:565.
29. Crompton, T., K. C. Gilmour, and M. J. Owen. 1996. The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell 86:243.
30. McLaughlin, K. A., B. A. Osborne, and R. A. Goldsby. 1996. The role of oxygen in thymocyte apoptosis. Eur. J. Immunol. 26:1170.
31. Smith, J. A., J. Yun Tso, M. R. Clark, M. S. Cole, and J. A. Bluestone. 1997. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J. Exp. Med. 185:1413.
32. Madrenas, J., L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/ partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185: 219.
33. + T cells. Science 271:1272.
34. + T cells. Science 271:1276.
35. 2-terminal kinase and mitogen-activated protein kinase signalling pathways. J. Exp. Med. 183:2017.
36. Chau, L., J. Bluestone, and J. Madrenas. 1998. Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor. J. Exp. Med. 187:1699.
37. Robey, E., D. Chang, A. Itano, D. Cado, H. Alexander, D. Lans, G. Weinmaster, and P. Salmon. 1996. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87:483.